5312.TWO · FORMOSA
Taiwan · RS rating 43 · As of 2026-10-08
| Price | 89.30 TWD |
|---|---|
| 1-day change | -0.1% |
| RS rating (overall / 1M / 3M / 12M) | 43 / 26 / 63 / 38 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 34 / 25 / 45 |
| Industry group (rank) | Medical-Biomed/Biotech (53) |
| EPS growth Q/Q | +47.3% |
| Sales growth Q/Q | -2.4% |
| Distance from 52-week high | +16.9% |
| Market cap (USD) | $168.7M |